Patients harboring tumors with PRKACA mutations were diagnosed with CS at younger ages (45.3 ± 13.5 vs. 52.5 ± 11.9 years) (Goh et al., 2014). This evidence concerns the gene PRKACA and Cowden syndrome 1.